高级搜索

131I 标记抗CD20 单克隆抗体在荷瘤裸鼠体内的放射免疫显像

Radioimmunoimaging of Anti-CD20 Monoclonal Antibody Labeled with 131I in Nude Mice Xenografted with Raji Cells Tumor in Vivo

  • 摘要: 目的 探讨131I-anti-CD20McAb经瘤内注射后在荷人Burkitt's淋巴瘤细胞系Raji细胞移植瘤裸鼠体内的放射免疫显像。方法 131I标记物的标记采用IODO-GEN碘化标记;注射标记物后第1、3、7、15天将荷瘤裸鼠SPECT显像后活杀,定标器测量并计算瘤、血等12种器官或组织的%ID/g值,根据MIRD委员会推荐的公式计算肿瘤累积吸收剂量。结果 131I-anti-CD20McAb瘤内注射组的SPECT显像结果优于腹腔注射组和131I-IgG瘤内注射组,该组肿瘤%ID/g值在给药后第1、3和7天分别为后两组的1.4~17倍和1.7~3.7倍,肿瘤累及吸收剂量在给药后第3、7和15天分别为后两组的1.5~2.5倍和6.0~12.6倍。结论 131I-anti—CD20McAb经瘤内途径给药可以使肿瘤获得最高的放射性药物摄取率.为下一步运用该途径进行放射免疫治疗提供了实验依据。

     

    Abstract: Objective  To exploit the radioimmunoimaging of iodine-131 labeled anti-CD20McAb with intratumor injection( IT) in nude mice xenografted with raji cells tumor. Methods  Iodine-131 labeled anti-CD20McAb by iodogen method. The mice were imaged by SPECT and killed following on one、three、seven and fifteen day after injection. The injected dose/ gramtissue ( %ID/ g) percentages of different organs, including tumor, blood, etal were measured by calibrator and calculated. Dosimetry of cumulate absorption in tumor was performed using MIRD formula. Results  131I-anti-CD20McAb IT group showed clearer images in tumors than int raperitoneal injection ( IP) and 131I-IgGIT control groups. The %ID/ g in tumor in 131I-anti-CD20McAb IT group were 1. 4~17 fold higher than that in IP group and 1. 7~3. 7 in IgG IT group, and the cumulate absorbed dose were 6. 0~12. 6 and 1. 5~2. 5 fold higher than the other two groups. Conclusion  Tumor could have the highest absorbed radioactive drugs with intratumor injection of 131I-anti-CD20McAb, which offered the experimental evidence for the next radioimmunotherapy.

     

/

返回文章
返回